Number of patients | 37 |
Age (years) | |
Median (Range) | 69.0 (50 - 80) |
Sex | |
Male | 26 (70.3%) |
Female | 11 (29.7%) |
Performance status | |
0 | 12 (32.4%) |
1 | 20 (54.1%) |
2 | 5 (13.5%) |
Histology | |
Adenocarcinoma | 26 (70.3%) |
Squamous cell carcinoma | 6 (16.2%) |
Unclassified | 5 (13.5%) |
Stage | |
IIIB | 8 (21.6%) |
IV | 29 (78.4%) |
Smoking history | |
Never | 14 (37.8%) |
Current or former | 22 (59.5%) |
Uncertainty | 1 (2.7%) |
Number of prior chemotherapy regimen(s) | |
1 | 26 (70.3%) |
2 | 11 (29.7%) |
EGFR gene status | |
Mutated (sensitive mutation) | 12 (32.4%) |
Wild-type | 15 (40.5%) |
Unknown | 10 (27.0%) |